Curcumin reverses neurochemical, histological and immuno-histochemical alterations in the model of global brain ischemia

Journal of Traditional and Complementary Medicine

Volumn 7, Issue 1, 2017, Pages 14-23

  de Alcântara, Glaura Fernandes Teixeira ^a   Simões Neto, Eudes ^a   da Cruz, Giovany Michely Pinto ^a   Nobre, Maria Elizabeth Pereira ^a   Neves, Kelly Rose Tavares ^a   de Andrade, Geanne Matos ^b   Brito, Gerly Anne de Castro ^b   Viana, Glauce Socorro de Barros ^a,b  

^a Laboratory of Pharmacology and Biophysiology   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Brain ischemia; Curcumin; Cytokines; Neuroinflammation; Neuroprotection

Indexed keywords

EID: 84971474729     PISSN: None     EISSN: 22254110     Source Type: Journal    
DOI: 10.1016/j.jtcme.2015.10.001     Document Type: Article

References (54)

1. 1 Donnan, G.A., Fisher, M., Macleod, M., Davis, S.M., Stroke. Lancet 371 (2008), 1612–1623.
2. 2 Towfighi, A., Saver, J.L., Stroke declines from third to fourth leading cause of death in the United States: historical perspectives and challenges ahead. Stroke 42 (2011), 2351–2355.
3. 3 Dirnagl, U., Iadecola, C., Moskowitz, M.A., Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22 (1999), 391–397.
4. 4 Bramlett, H.M., Dietrich, W.D., Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab 24 (2004), 133–150.
5. 5 Graham, S.H., Chen, J., Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab 21 (2001), 99–109.
6. 6 Liu, P.K., Hamilton, W.J., Hsu, C.Y., Apoptosis: DNA damage and repair in stroke. Miller, L.P., (eds.) Stroke Therapy Basic, Preclinical, and Clinical Directions, vol. 11, 1999, John Wiley & Sons Inc, 299–320.
7. 7 Snider, B.J., Gottron, F.J., Choi, D.W., Apoptosis and necrosis in cerebrovascular disease. Ann N Y Acad Sci 893 (1999), 243–253.
8. 8 Martin, L.J., Sieber, F.E., Traystman, R.J., Apoptosis and necrosis occur in separate neuronal populations in hippocampus and cerebellum after ischemia and are associated with differential alternations in metabotropic glutamate receptor signaling pathways. J Cereb Blood Flow Metab 20 (2000), 153–167.
9. 9 Maier, C.M., Chan, P.H., Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 8 (2002), 323–334.
10. 10 Globus, M.Y., Alonso, O., Dietrich, W.D., Busto, R., Ginsberg, M.D., Glutamate release and free radical production following brain injury: effects of posttraumatic hypothermia. J Neurochem 65 (1995), 1704–1711.
11. 11 Chan, P.H., Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21 (2001), 2–14.
12. 12 Bethea, J.R., Dietrich, W.D., Targeting the host inflammatory response in traumatic spinal cord injury. Curr Opin Neurol 15 (2002), 355–360.
13. 13 Jin, R., Yang, G., Li, G., Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87 (2010), 779–789.
14. 14 Oliveira, J.A., Carvalho, E.T., Araújo, A.C., Lopes, M.J.P., Cruz, G.M.P., Viana, G.S.B., Evaluation of the analgesic and anti-inflammatory properties of curcumin at low doses. XXIII Simposium of Brazilian Medicinal Plantas, Goiânia, GO, September 2014, 2014.
15. 15 Liu, L., Zhang, P., Li, Y., Yu, G., Curcumin protects brain from oxidative stress through inducing expression of UCP2 in chronic cerebral hypoperfusion aging-rats. Mol Neurodegener, 7(suppl 1), 2012, S10.
16. 16 Zhu, H.T., Blan, C., Yuan, J.C., et al. Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-kB signaling pathway in experimental traumatic brain injury. J Neuroinflammation, 11, 2014, 59.
17. 17 Chattopadhyay, I., Biswas, K., Bandyopadhyay, Banerjee, R.K., Turmeric and curcumin: biological actions and medicinal application. Curr Sci 87 (2004), 44–53.
18. 18 Sharma, R.A., Gescher, A.J., Steward, W.P., Curcumin: the story so far. Eur J Cancer 41 (2005), 1955–1968.
19. 19 Yang, C., Zhang, X., Fan, H., Liu, Y., Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 1282 (2009), 133–141.
20. 20 Yu, G., Liu, L., Zhang, P., Li, Y., Protective effect of curcumin on chronic cerebral ischemia by altering expression of alpha-synuclein in 2VO model. Mol Neurodegener, 2012, 10.1186/1750-1326-7-51-533.
21. 21 Liu, Z.-J., Liu, W., Liu, L., Xiao, C., Wang, Y., Jiao, J.-S., Curcumin protects neuron against cerebral ischemia-induced inflammation through improving PPAR-gamma function. Evid Based Complement Altern Med, 2013, 2013, 10, 470975, 10.1155/2013/470975.
22. 22 Wu, J., Li, Q., Wang, X., et al. (2013). Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway. PloS One, 8(3), 2013, e59843, 10.1371/journal.pone.0059843.
23. 23 Tu, X.K., Yang, W.Z., Chen, J.P., et al. Curcumin inhibits TLR2/4-NF-kB signaling pathway and attenuates brain damage in permanent focal cerebral ischemia in rats. Inflammation 37 (2014), 1544–1551.
24. 24 Mukunda, M., Mythri, S.B., Harish, R.B., et al. Neuroprotection by the dietary polyphenol curcumin: therapeutic implications for Parkinson's disease. 16th International Congress of Parkinson's Disease and Movement Disorders, Dublin, Ireland, 2012.
25. 25 Cole, G.M., Teter, B., Frautschy, S.A., Neuroprotective effects of curcumin. Adv Exp Med Biol 595 (2007), 197–212.
26. 26 Lakhan, S.E., Kirchgessner, A., Hofer, M., Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med, 2009, 97, 10.1186/1479-5876-7-97.
27. 27 Shichita, T., Sakaguchi, R., Suzuki, M., Yoshimura, A., Post-ischemic inflammation in the brain. Front Immunol, 3, 2012, 10.3389/fimmu2012.00132.
28. 28 Lee, S., Suh, S., Kim, S., Protective effects of the green tea polyphenol (-)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci Lett 287 (2000), 191–194.
29. 29 Harik, S.I., Yoshida, S., Busto, R., Ginsberg, M.D., Monoamine neurotransmitters in difuse reversible forebrain ischemia and early recirculation: increased dopaminergic activity. Neurology 36 (1986), 971–976.
30. 30 Vamyakidès, A., Cerebral ischemia: massive increase of the dopamine release or stagnation?. Ann Pharm Fr 50 (1992), 277–289.
31. 31 Phebus, L.A., Clemens, J.A., Effects of transient, global, cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites. Life Sci 44 (1989), 1335–1342.
32. 32 Obrenovitch, T.P., Sarna, G.S., Matsumoto, T., Symon, L., Extracellular striatal dopamine and its metabolites during transient cerebral ischaemia. J Neurochem 54 (1990), 1526–1532.
33. 33 Kawano, T., Tsutsumi, K., Miyake, H., Mori, K., Striatal dopamine in acute cerebral ischemia of stroke-resistant rats. Stroke 19 (1988), 1540–1543.
34. 34 Frölich, I., Dirr, A., Riederer, P., Hoyer, S., Effects of long-term recovery from transient cerebral ischemia in rat brain: tissue levels of acetylcholine, monoamines, and their metabolites. Neurochem Res 18 (1993), 1239–1244.
35. 35 Kulkarni, S.K., Bhutani, M.K., Bishoi, M., Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology 201 (2008), 435–442.
36. 36 Kulkarni, S.K., Dhir, A., Akula, K.K., Potentials of curcumin as an antidepressant. Sci World J 9 (2009), 1233–1241.
37. 37 Buthani, M.K., Bishnoi, M., Kulkarni, S.K., Antidepressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical chnges. Pharmacol Biochem Behav 92 (2009), 39–43.
38. 38 Lopresti, A.L., Hood, S.D., Drummond, P.D., Multiple antidepressant modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immunomodulatin and neuroprotective effects. J Psychopharmacol 26 (2012), 1512–1524.
39. 39 Patel, A.R., Ritzel, R., McCullough, L.D., Liu, F., Microglia and ischemic stroke: a double-edge sword. Int J Physiol Pathophysiol Pharmacol 5 (2013), 73–90.
40. 40 Guo, L., Xing, Y., Pan, R., et al. Curcumin protects microglia and primary rat cortical neurons against HIV-1 gp120-mediated inflammation and apoptosis. Plos One, 8(8), 2013, e70565, 10.1371/journal.pone.0070565.
41. 41 Karlstetter, M., Lippe, E., Walczak, Y., et al. Curcumin is a potent modulator of microglial gene expression and migration. J Neuroinflammation, 2011(8), 2011, 12.
42. 42 Menon, V.P., Sudheer, A.R., Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 595 (2007), 105–125.
43. 43 Rao, C.V., Regulation of COX and LOX by curcumin. Adv Exp Med Biol 595 (2007), 213–226.
44. 44 Liu, T., Clark, R.K., McDonnell, P.C., et al. Tumor necrosis factor-alpha expression inmischemic neurons. Stroke 25 (1994), 1481–1488.
45. 45 Feuerstein, G.Z., Liu, T., Barone, F.C., Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc Brain Metab Rev 6 (1994), 341–360.
46. 46 Barone, F.C., Arvin, B., White, R.F., et al. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28 (1997), 1233–1244.
47. 47 Cho, J.W., Lee, K.S., Kim, C.W., Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int J Mol Med 19 (2007), 469–474.
48. 48 Kim, Y.S., Ahn, Y., Hong, M.H., et al. Curcumin attenuates inflammatory responses of TNF-alpha stimulated human endothelial cells. J Cardiovasc Pharmacol 50 (2007), 41–49.
49. 49 Aggarwal, B.B., Gupta, S.C., Sung, B., Curcumin: an orally bioavailable blocker of TNF-alpha and other pro-inflammatory biomarkers. Brit J Pharmacol 169 (2013), 1672–1692.
50. 50 Domaç, F., Somay, G., Missrlt, H., Erenoglu, N.Y., Tumor necrosis factor alpha serum levels and inflammatory response in acute stroke. Neurosciences 12 (2007), 25–30.
51. 51 Begum, A.N., Jones, M.R., Lim, G.P., et al. Curcumim structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. Pharmacol Exp Ther 326 (2008), 196–208.
52. 52 Sikora, E., Scapagnini, G., Barbagallo, M., Curcumin, inflammation, ageing and age-related diseases. Immun Ageing, 7, 2010, 1.
53. 53 Basnet, P., Skalko-Basnet, N., Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16 (2011), 4567–4598.
54. 54 Koeberle, A., Muñoz, E., Appendino, G.B., et al. SAR studies on curcumin's pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase. J Med Chem 57 (2014), 5638–5648.